Press Release
TGaS Advisors Named to 2009 INC 500/5000, Ranked First in Business Products & Services in the Mid-Atlantic Region
East Norriton, Penn., August 27, 2009 — TGaS Advisors®, the leader in benchmark and advisory services for pharmaceutical commercial organizations, has been recognized for the second year in a row as one of the fastest-growing private companies in the United States by Inc. Magazine in its 2009 rankings.
TGaS Advisors ranks first in Business Products & Services and 11th overall in the Mid-Atlantic region (PA-NJ-DE-MD). The company also placed in the top 50 nationwide for Business Products & Services, and was ranked #522 in overall national listings. Despite the difficult economic climate, TGaS Advisors achieved a three-year growth rate of more than 500 percent, introducing new benchmarks in Commercial Compliance, Integration Services and Sales Leadership, adding to its client roster and providing deeper services to existing clients. The company has added staff, including the recent appointment of Anthony Sorce as Vice President for New Business Development.
Managing Partner Stephen E. Gerard attributes TGaS Advisors’ growth to the firm’s experienced leadership, collaborative relationship with clients and the flexibility to grow as clients require more strategic services. According to Gerard, “TGaS Advisors’ achievements arise from our unique concept of working as Trusted Advisors from the ‘outside-in,’ creating a community of pharmaceutical executives and providing confidential fact-based answers to the question, ‘How do other pharmaceutical companies do “it”?’®”
Most TGaS Advisors associates are 20-year industry veterans, coming to the firm from such companies as Wyeth, Roche Pharmaceuticals, Schering-Plough, King Pharmaceuticals, Abbott Laboratories, Yamanouchi (Astellas), Thomson Reuters, IMS Health and SimStar (Rosetta Interactive). Senior advisors communicate findings exclusively to peer-set participants, providing insights specific to each client and addressing strategy, tactics and optimal practices based on results and industry experience.
The Inc. 5000 is ranked according to percentage revenue growth from 2005 through 2008. To qualify, companies must be U.S.-based, privately held, for profit and independent – not subsidiaries or divisions of other companies – as of December 31, 2008. Revenue in 2005 must have been at least $200,000, and revenue in 2008 must have been at least $2 million. The top 10 percent of companies on the list comprise the Inc. 500, now in its 28th year. (www.inc.com)
About TGaS® Advisors
TGaS Advisors, ranked in the top 50 among U.S. Business Products & Services companies by the Inc. 500, is the leader in benchmarking and advisory services to the pharmaceutical and biopharmaceutical industry. The TGaS Advisors roster includes nine of the top 10 and the majority of the top 50 pharmaceutical companies with operations in the U.S. market. The firm’s benchmarking and advisory services suite of solutions, PharmaStance®, provides clients with a way to measure where they stand with respect to their organizations and answers the question, “How do other pharmaceutical companies do ‘it’?”®, TGaS Advisors is based in East Norriton, Pennsylvania.
- Other 2009:
- TGaS Advisors’ Gerard Featured on Executive Leaders Radio
- TGaS Advisors Hosts Pharma Commercial Operations Summit on 2010 Trends
- TGaS Advisors’ Donna Wray Invited to Present Benchmark Findings and Recommendations on Digital Marketing Issues at DDMAC Hearings
- The Right Skill Sets for Pharma More Critical Than Ever in 2009, According to TGaS Advisors Organizational Career Guide
- TGaS Advisors Sample Accountability Benchmark Shows Stepped-Up Focus on Compliance Operations
- TGaS Advisors Named to Philadelphia 100®
- Brian Deppen Joins TGaS Advisors Managed Markets Practice
- Managed Markets Leaders Identify Most Urgent Concerns
- TGaS Advisors Appoints Anthony Sorce, Vice President, New Business Development and Jeff Wojcik Promoted to Principal
- Commercial Compliance Benchmark Charts Promotional Monitoring by Pharmaceutical Companies
- Critical Job Skills, Career Progression are Key Issues for Sales Ops Leadership
- Taking “Closed Loop” to the Next Level: Re-Imagining Sales and Managed Markets as an Interactive System
- TGaS Advisors Convenes “Mega-Summit” for Pharma Leaders on the Impact of Industry Trends on Commercial Organizations
- FDA Letters Hobble a Favorite Relationship Marketing Tactic of TGaS Advisors Benchmark Companies Page
- TGaS Advisors Analytics Experts Urge Pharma Management Sciences Professionals to Help Shape Industry Future
- TGaS Advisors Appoints Curt Staab Director, Management Advisor, Sales Advisory Practice
- TGaS Advisors Offers Benchmark-based Services to Support Integration Following Recent Wave of Mergers & Acquisitions
- TGaS Advisors Introduces Commercial Compliance Benchmark